BeStock  
Stocks › Biotechnology › EPRX

Eupraxia Pharmaceuticals EPRX

US equityMarket cap rank #3682Biotechnology
$5.80 −$0.32 (-5.23%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.80 0.00%
Open$6.11
Prev close$6.12
Day range$5.69 – $6.42
Volume361.7K
Market cap$390.16M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership43.1%-0.75 pts vs. prior quarter
Institutions holding76+1 vs. prior quarter
Insider trades (recent)0 buys / 1 sellsNet selling
Short interest9.45% of floatDays to cover 10.4 · as of 30 Oct 2026
Short-sale volume share14.2%5-day average of daily volume

Short-sale volume as % of daily volume

4%13%23%33%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$778.1K (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

+$1.1MSuper−$294.6KBig−$263.4KMid−$309.8KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 21.1% of shares outstanding.

Largest holders

  • Robert Disbrow5.41%
  • Beutel Goodman & Company Ltd.5.35%
  • Manchester Management Company, LLC4.00%
  • Joseph Freedman3.86%
  • Affinity Asset Advisors, LLC2.50%
  • John Montalbano2.36%
  • Scotiabank Global Banking and Markets, Asset Management Division2.16%
  • Balyasny Asset Management L.P.2.05%

By investor type

  • Hedge Fund20.86%
  • Individual/Insider15.53%
  • Mutual Fund14.57%
  • VC/PE Fund5.69%
  • Private Company1.30%
  • Public Company0.70%
  • Family Office/Trust0.18%

Reported short interest has fallen from 9.64% to 9.45% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
State Street Global Advisors Mutual Fund 2026/Q3 +46,532 0.1%
BlackRock Mutual Fund 2026/Q3 +140,898 0.2%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +85,664 0.2%
Scotiabank Global Banking and Markets, Asset Management Division Mutual Fund 2026/Q3 +81,339 2.2%
Janus Henderson Group plc Mutual Fund 2026/Q3 +1,046,000 1.6%
PFM Health Sciences, LP Hedge Fund 2026/Q3 +669,790 1.8%
Millennium Management LLC Hedge Fund 2026/Q3 +441,586 0.7%
Picton Mahoney Asset Management Mutual Fund 2026/Q3 +360,878 0.5%
Woodline Partners LP Hedge Fund 2026/Q3 +306,313 1.1%
Jane Street Group, LLC Private Company 2026/Q3 +293,843 0.5%
DV Equities, LLC Mutual Fund 2026/Q3 +276,000 0.4%
Citadel Advisors LLC Hedge Fund 2026/Q3 +271,835 0.8%
OrbiMed Advisors LLC VC/PE Fund 2026/Q3 +269,000 0.4%
Dafna Capital Management, LLC Hedge Fund 2026/Q3 +225,600 0.3%
Two Sigma Investments, LP Hedge Fund 2026/Q3 +210,284 0.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
7 Mar 2026 Richard Glickman Independent Director Other Derivative Disposition -3,125 – –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 6,246,800 9.5% 10.4
15 Oct 2026 6,538,961 9.9% 5.3
30 Sep 2026 6,798,798 10.3% 11.1
15 Sep 2026 7,582,355 11.5% 11.3
31 Aug 2026 7,112,440 10.8% 18.5
14 Aug 2026 6,336,985 9.6% 28.8

Discussion

No comments yet — be the first to weigh in on EPRX.

Sign in to join the discussion.

Scroll to Top